Showing results (31-40 of 839) with videos related to
Sort By:
Pageof 84
Gut|October 7, 2021
Novel therapeutic targets for cholestatic and fatty liver diseaseMichael Trauner, Claudia Daniela FuchsLiver International : Official Journal of the International Association for the Study of the Liver|July 7, 2005
Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapySrinivas Seela, Harinath Sheela, James L BoyerMolecular Aspects of Medicine|December 17, 2013
Clinical application of transcriptional activators of bile salt transportersAnna Baghdasaryan, Peter Chiba, Michael TraunerSeminars in Liver Disease|November 14, 2013
Bile acid-mediated control of liver triglyceridesClaudia Fuchs, Thierry Claudel, Michael TraunerNature Clinical Practice. Gastroenterology & Hepatology|September 30, 2006
Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsisAndreas Geier, Peter Fickert, Michael TraunerDigestive Diseases (Basel, Switzerland)|March 2, 2017
Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver DiseasesEmina Halilbasic, Daniel Steinacher, Michael TraunerDigestive Diseases (Basel, Switzerland)|March 2, 2017
Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver DiseaseDaniel Steinacher, Thierry Claudel, Michael TraunerSeminars in Liver Disease|February 14, 2007
MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromesMichael Trauner, Peter Fickert, Martin WagnerJournal of Hepatology|July 15, 2009
New molecular insights into the mechanisms of cholestasisMartin Wagner, Gernot Zollner, Michael TraunerPharmacology & Therapeutics|April 15, 2010
Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicityGernot Zollner, Martin Wagner, Michael TraunerPageof 84